Pneumonia in the patient with chronic obstructive pulmonary disease. Levels of severity and risk classification;Neumonía en el paciente con enfermedad pulmonar obstructiva crónica. Niveles de gravedad y clases de riesgo

Archivos de Bronconeumologia

Volumn 39, Issue 3, 2003, Pages 101-105

  Ruiz de Ona J M ^a   Gomez Fernandez M ^a   Celdran J ^a   Puente Maestu, L ^b  

^a HOSPITAL NUESTRA SEÑORA DEL PRADO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

COPD; Pneumonia; Risk

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN THERAPY; PNEUMONIA; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 0344951012     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13044147     Document Type: Article

References (16)

1. Sobradillo V, Miravitlles M, Jiménez CA, Gabriel R, Viejo JL, Fernando Masa J, et al. Estudio IBEREPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo. Arch Bronconeumol 1999;35:159-66.
2. Soler JJ, Sánchez L, Latorre M, Alamar J, Román P, Perpiñá M. Impacto asistencial hospitalario de la EPOC. Peso específico del paciente con EPOC de alto consumo sanitario. Arch Bronconeumol 2001;37:375-81.
3. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1256-76.
4. Fine MJ, Auble ThE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
5. Almirall J, González CA, Balanzó X, Bolíbar I. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest 1999;116:375-9.
6. Torres A, Dorca J, Zalacaín R, Bello S, El-Ebiary M, Molinos L, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease. A Spanish multicenter study. Am J Respir Crit Care Med 1996;154:1456-61.
7. Farr BM, Woodhead MA, Macfarlane JT, Bartleti CL, McCracken JS, Wadsworth J, et al. Risk factors for community-acquired diagnosed by general practitioners in the community. Respir Med 2000;94:422-7.
8. Murray CJL, López AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996;274:740-3.
9. Miravitlles M, Figueras M. El coste de la enfermedad pulmonar obstructiva crónica en España. Opciones para la optimización de recursos. Arch Bronconeumol 2001;37:388-93.
10. Sanchís J, Casán P, Castillo J, González N, Palenciano L, Roca J. Espirometría forzada. En: Recomendaciones SEPAR. Barcelona: SEPAR, 1998; p. 1-18.
11. Riquelme R, Torres A, el-Ebiary M, de la Bellacasa JP, Estruch R, Mensa J, et al. Community-acquired pneumonia in the elderly. A multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 1996;154:1450-5.
12. Lim WS, Lewis S, Macfarlane JT. Severity prediction rules in community acquired pneumonia: a validation study. Thorax 2000;55:219-23.
13. Confalonieri M, Potena A, Carbone G, Della Porta R, Tolley EA, Meduri GU. Acute respiratory failure in patients with severe community-acquired pneumonia. Am J Respir Crit Care Med 1999;160:1585-91.
14. Ruiz M, Ewig S, Torres A, Arancibia F, Marco F, Mensa J, et al. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med 1999;160:923-9.
15. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54.
16. Almirall J, Bolíbar I, Balanzó X, González CA. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 1999;13:349-55.